LMP2a-specific cytotoxic T-lymphocytes

· Baylor College of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LMP2a-specific cytotoxic T-lymphocytes, covering 2017-02-07 to 2017-02-07. Get the full timeline:

Most recent: Clinical Trial Update: LMP2a-Specific Cytotoxic T-Lymphocytes, Lymphoma (ACDAL) [Phase 1]